re: Ann: Pharmaxis Announces Positive Combine... And we must also keep in mind that a second phase 3 trial is currently active for the use of Bronchitol for bronchiectasis.
There are approx. 600,000 sufferers worldwide with no drug currently proven effective to clear mucus.
Although this trial is not expected to release data until 2012, there is the potential that with a favourable outcome Bronchitol would be approved for this indication as well.
The potential really is great for this medication.
- Forums
- ASX - By Stock
- SNT
- Ann: Pharmaxis Announces Positive Combined Phase
Ann: Pharmaxis Announces Positive Combined Phase , page-13
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $45.37M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.7¢ | $66.86K | 1.754M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 82150 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.8¢ | 452640 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 400000 | 0.036 |
4 | 1223863 | 0.035 |
1 | 200000 | 0.034 |
1 | 400000 | 0.033 |
1 | 100000 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.038 | 452640 | 1 |
0.039 | 156137 | 1 |
0.043 | 25000 | 1 |
0.045 | 45224 | 1 |
0.046 | 70076 | 2 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online